Abstract:Background: Currently, the prevalence of Alzheimer's disease (AD) is progressively rising, particularly in developed nations. There is an escalating focus on the onset and progression of AD. A mounting body of research indicates that epigenetics significantly contributes to AD and holds substantial promise as a novel therapeutic target for its treatment. Objective: The objective of this article is to present the AD areas of research interest, comprehend the contextual framework of the subject research, and investigate the prospective direction for future research development. Methods: ln Web of Science Core Collection (WOSCC), we searched documents by specific subject terms and their corresponding free words. VOSviewer, CiteSpace and Scimago Graphica were used to perform statistical analysis on measurement metrics such as the number of published papers, national cooperative networks, publishing countries, institutions, authors, co-cited journals, keywords, and visualize networks of related content elements. Results: We selected 1,530 articles from WOSCC from January 2013 to June 2023 about epigenetics of AD. Based on visual analysis, we could get that China and United States were the countries with the most research in this field. Bennett DA was the most contributed and prestigious scientist. The top 3 cited journals were Journal of Alzheimer's Disease, Neurobiology of Aging and Molecular Neurobiology. According to the analysis of keywords and the frequency of citations, ncRNAs, transcription factor, genome, histone modification, blood DNA methylation, acetylation, biomarkers were hot research directions in AD today. Conclusion: According to bibliometric analysis, epigenetic research in AD was a promising research direction, and epigenetics had the potential to be used as AD biomarkers and therapeutic targets.

The Epigenetics of Alzheimer’s Disease: Factors and Therapeutic Implications

Epigenetic Modification and Its Role in Alzheimer's Disease

Epigenetic mechanisms in Alzheimer's disease: implications for pathogenesis and therapy.

Epigenetic Changes in Alzheimer's Disease: DNA Methylation and Histone Modification

Targeting epigenetic mechanisms in amyloid-β-mediated Alzheimer's pathophysiology: unveiling therapeutic potential

Progresses on study of epigenetics in neurodegenerative disorders

Epigenetic regulation in Alzheimer’s disease: is it a potential therapeutic target?

DNA methylation: The epigenetic mechanism of Alzheimer's disease

An Epigenetic Manifestation of Alzheimer's Disease: DNA Methylation

Epigenetics in Alzheimer’s Disease: Perspective of DNA Methylation

Epigenetic modifications of DNA and RNA in Alzheimer's disease

A Bibliometric and Visual Analysis of Epigenetic Research Publications for Alzheimer’s Disease (2013–2023)

A bibliometric and visual analysis of epigenetic research publications for Alzheimer's disease (2013–2023)

Epigenetics and DNA methylomic profiling in Alzheimer's disease and other neurodegenerative diseases

An integrated multi-omics approach identifies epigenetic alterations associated with Alzheimer’s disease

Genetics of Alzheimer’s disease: From pathogenesis to clinical usage

Epigenetic Explorations of Neurological Disorders, the Identification Methods, and Therapeutic Avenues

Epigenetic Alterations in Alzheimer's Disease: Impact on Insulin Signaling and Advanced Drug Delivery Systems

Exploring the Therapeutic Potential of Natural Compounds for Alzheimer's Disease: Mechanisms of Action and Pharmacological Properties.

Epigenetic Inhibitors as Alzheimer's Disease Therapeutic Agents

Transcriptional Regulation and Its Misregulation in Alzheimer’s Disease